Bill Booth kindly invited me on to his podcast to discuss health and medicine. Bill is one of the founders of Radical Americas, an academic network for scholars and activists with interests in radicalism in the Western Hemisphere.
The ADHS is excited to announce that its next bi-annual conference will be held between 12 and 15 June 2019, at the David F. Musto Center for Drug Policy Studies, Shanghai University, China. The conference will be organised by Prof. Jim Mills, of the University of Strathclyde and Prof. Yong-an Zhang of Shanghai University, who […]
A great day for historians of drugs and alcohol! Told in tweets.
Check it out.
Mental health knowledge and practice was highly contested in the 1960s and 70s. Struggles over homosexuality and radicalism, drug use and replicable drug trials, were part of a unique countercultural moment. These were wild times. Transactional analysis, developed by Eric Berne and Claude Steiner, was also part of this fiercely energetic moment.
In January 2017 Claude Steiner (pictured above), a clinical psychologist, passed away in California. According to his obituary in the San Francisco Chronicle, Steiner’s last words were, ‘Love is the answer’ and ‘I’m so lucky’. He had led a long and full life, and left behind an important legacy in psychology. Steiner was a founder of the Radical Therapist Collective, protested at American Psychiatric Association and American Psychological Association meetings, and edited a collection of Readings in Radical Psychiatry in 1975. Steiner also published a short children’s story called The Warm Fuzzy Tale in 1969 and Games Alcoholics Play in 1970. In 1974, he followed these books up with Scripts People Live, which was a bestseller in the United States. Most importantly, Steiner was influential in developing and popularising transactional analysis.
Steiner was born in France, relocated to Mexico, and then moved to California in 1952 to study physics. But in the aftermath of atomic explosions in Hiroshima and Nagasaki, and seeing how physics was associated with nuclear weapons, he rejected the field. The link to bombs and bomb-making put him off. Transferring to psychology and eventually obtaining his doctorate from the University of Michigan in 1965, he became a close associate of Eric Berne. Set against the backdrop of a topsy-turvy mental health landscape, it is clear that their story had an important impact on psychology – during a unique moment in time – through the creation of transactional analysis.
The full article can be read here
Enjoy. And I’ve written similar work on the 1960s and mental health:
with Social History of Medicine…
and Hidden Persuaders…
Today I write for the Saskatoon StarPhoenix and Regina Leader-Post.
The story of cancer patient Ric Richardson, a Métis man from Green Lake, challenges us to think about patient autonomy, medical traditions and Saskatchewan health care.
Just as crucial, his story forces us to reconsider the use and acceptance of traditional Aboriginal knowledge — not only in medicine but in society more broadly.
The full story can be read here:
This past week the UK Government released a Drugs Strategy. Here is some of the reaction to the document, which is available here.
From The Independent:
The Government’s latest policy relaunch aimed at tackling illegal drugs amid soaring death rates has been heavily criticised by campaigners who say it fails to get to grips with the problem.
The UK Drug Strategy 2017 was announced by the Home Office as its flagship initiative to reduce use of illicit substances and improve addiction recovery rates.
Drug misuse has been falling in recent years, figures show. Some 2.7 million 16- to 59-year-olds in England and Wales took illegal drugs in 2015-16, down from 10.5 per cent a decade ago.
However, the latest available figures also reveal deaths are soaring. Some 3,674 drug poisoning deaths involving legal and illegal substances were recorded in 2015, up from 3,346 in 2014 and the most since comparable records began in 1993. Cocaine deaths reached an all-time high in 2015, and deaths involving heroin and/or morphine doubled over three years to reach record levels.
The new Home Office strategy identifies new emergent threats, including drugs previously known as legal highs such as Spice – the drug blamed for causing a “zombie plague” in city centres, which is now causing havoc in the prison system.
Chemsex drugs like crystal meth, GHB/GBL and mephedrone, which are taken before or during sex to boost the experience, are also identified as a growing problem among users who expose themselves to blood-borne infections and viruses, according to the strategy.
It promises “targeted interventions” and close collaboration between sexual health services and other relevant groups, as well as more help for addicts to find houses and jobs and better controls at borders.
However, it immediately came under fire from people and organisations campaigning to reduce the harm caused by drugs.
Some argued that by refusing to countenance any sort of decriminalisation it could never make any serious dent in a trade controlled by organised criminals at an estimated cost to society of £10.7bn a year.
Models in countries such as Portugal were cited, where decriminalising drugs and treating their use as a health issue has reduced consumption, addiction and funding for criminals.
From the Daily Mail:
The Government has ‘no intention’ of making cannabis legal in the UK, officials have announced in a new blitz on drugs.
Despite a growing body of evidence showing the world’s favourite recreational drug to be safe, possession will remain punishable with jail.
Experts have slammed the Home Office’s controversial decision, describing it as a ‘missed opportunity’ to legalise the herb.
But ministers pointed to various studies that have shown cannabis to be detrimental to human health, with significant links to schizophrenia.
Such worrying associations have existed for decades, and were responsible the decision to reclassify the drug to a Class B nine years ago.
In recent years, Spain, South Africa, Uruguay and several states in the US have made cannabis legal for recreational use.
Pressure has been increasing on the UK to follow suit and update its drug policy, with many citing weed’s medicinal properties.
But Ian Hamilton, a drug researcher based at York University, told MailOnline the UK’s updated stance shows it’s falling behind.
He said: ‘The government has missed an opportunity to provide less harmful ways of people accessing and using cannabis.
‘The UK is falling behind many other countries who are adopting progressive policies towards drug use.
‘These countries have embraced the evidence and recognise that punishing people who use drugs does not improve their health and adds to social inequality.’
Cannabis is currently a Class B drug in the UK, and anyone found in possession can face up to five years in prison.
From The Guardian:
The wait is finally over for those of us working in the drug policy and drug treatment sectors. The Home Office published its new drug strategy on Friday, two years after its planned deadline in 2015. Sadly, however, this is not a case of good things coming to those who wait. For a 50-page document, there’s very little in the new strategy that can earn it its name.
Against a backdrop of increasing policy innovation in the wider world, the main aims of this strategy are largely unchanged from the previous 2010 version. There’s still a focus on recovery, rather than harm reduction. A continued commitment to tackling the problems caused by drugs through the criminal justice system, rather than through the health system. A point blank refusal to consider decriminalisation, or any reforms to the Misuse of Drugs Act.
Worse, what good initiatives there are in the strategy – and there are some – seem to have been dreamed up by minds unfettered by the reality of public health, criminal justice and policing systems squeezed to breaking point.
Andy Burnham, giving the keynote address at a conference in Manchester last week aimed at developing a more connected response to the city’s rising spice epidemic, echoed the thoughts of many in these fields: “Where is the money? Our frontline services are being overwhelmed. I didn’t hear any mention of any extra funding in the radio this morning. It seems quite hollow, what was being said.”
First then, for the good news. Greater efforts are going to be made to provide effective, evidence-based drug prevention and education to young people. Gone are the school visits from the trite ex-user or the finger-wagging police officer: effective resilience training is in.
Prisoners, too, are to be given more help into recovery, their progress monitored closely. Far clearer and more explicit guidelines have been given on the value of opioid maintenance treatments, which allow so many people with opioid dependence to live their lives, and crucially, prevent overdoses.
The people who slip through the cracks of dual diagnosis from mental health and problem substance use are to be better catered for, rather than shunted between services reluctant to take on complex and demanding cases.
Of the rather pedestrian reforms, these are the brightest spots. However, with cuts to local authority public health budgets totalling £85m this year, and ringfenced drug treatment budgets expected to be cut by £22m, it’s anyone’s guess as to where the money will come from for such initiatives. More likely that these reductions will further eat into essential services such as needle exchanges, and hamper local authorities’ ability to properly assess the performance of the services they commission.
(Read the whole article using the link above)
From The Huffington Post:
The Government’s new drugs strategy has been condemned as “business for usual” for failing to embrace radical solutions to soaring drug deaths.
The Home Office announced its long-awaited strategy that pledges to crack down on drug dealers and cut demand by expanding education on drugs and alcohol and expanding the Prevention Information Service.
Writing on HuffPost UK, Home Secretary Amber Rudd said the plan would target “unscrupulous drug dealers” while trying to do more to “protect the vulnerable – to prevent them falling into the cycle of drug abuse and to help them turn their lives around”.
While the new strategy does call a rise in drug deaths “dramatic and tragic”, it was condemned as “business as usual” by one advocate for change.
Niamh Eastwood, executive director of drug law experts Release, told HuffPost UK the strategy should have mooted ending criminal punishment for possession, following the lead of other countries.
If you have other stories and media accounts that you think should be added, get in touch.
It’s my pleasure to promote the publication of an important Policy Brief on Cannabis by Kathleen Thompson. Over the past few years she has helped drive conversations about the consumption and control of marijuana. Her recent Policy Brief ought to be read by anyone and everyone! Here’s an extract.
LEGALIZATION OF CANNABIS: THE POLICY CHALLENGES AND OPPORTUNITIES
By Kathleen Thompson, PhD, MSW, RSW, BA (Hons)
“The commitment by the Government of Canada to legalize cannabis
and cannabis products presents a complex range of socio-economic
challenges and opportunities. Creating the right legal and regulatory
framework to address the implications, both good and bad, will be
key in determining whether legalization is deemed successful public
The federal government plans to introduce cannabis legislation in the
coming spring session of Parliament. The legislation will be based on
the recommendations contained in a report issued on November 30 by
a Task Force of experts who studied the issue for the past year. The Task
Force received input from more than 30,000 Canadians, organizations
and professionals. Entitled “A Framework for the Legalization and
Regulation of Cannabis in Canada”, the report recommends allowing
more flexibility in the current federally controlled cannabis cultivation
model. Specifically, the federal government would regulate a safe and
responsible supply chain of cannabis.”
ABOUT KATHLEEN THOMPSON
Dr. Thompson has worked in health policy analysis and research as a bureaucrat and as a consultant for the last 25 years, specializing in the mental health, disability and corrections sectors.
In 2015, Dr. Thompson created the Cannabis Regulatory Research Group. The focus of the policy research group is on promoting collaborative public policy processes and evidenced-based research with the cannabis industry, governments, academia, civil society and at the United Nations. Additionally, Dr. Thompson consults with individuals and organizations on how to enter the legal cannabis industry.